000 | 01751 a2200517 4500 | ||
---|---|---|---|
005 | 20250513072651.0 | ||
264 | 0 | _c19930812 | |
008 | 199308s 0 0 eng d | ||
022 | _a0195-668X | ||
024 | 7 |
_a10.1093/eurheartj/14.6.836 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDakak, N | |
245 | 0 | 0 |
_aHaemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy. _h[electronic resource] |
260 |
_bEuropean heart journal _cJun 1993 |
||
300 |
_a836-44 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAldosterone _xblood |
650 | 0 | 4 |
_aAtrial Natriuretic Factor _xblood |
650 | 0 | 4 |
_aCardiac Output _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNitroglycerin _xadministration & dosage |
650 | 0 | 4 |
_aQuinolines _xadministration & dosage |
650 | 0 | 4 |
_aRenin _xblood |
650 | 0 | 4 |
_aVasodilator Agents _xadministration & dosage |
700 | 1 | _aMakhoul, N | |
700 | 1 | _aMerdler, A | |
700 | 1 | _aYechiely, H | |
700 | 1 | _aKahana, L | |
700 | 1 | _aHalon, D A | |
700 | 1 | _aSchneeweiss, A | |
700 | 1 | _aLewis, B S | |
773 | 0 |
_tEuropean heart journal _gvol. 14 _gno. 6 _gp. 836-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/eurheartj/14.6.836 _zAvailable from publisher's website |
999 |
_c8324593 _d8324593 |